表紙
市場調查報告書
商品編碼
971941

全球過敏免疫療法的市場規模調查:不同治療,各過敏,各銷售管道及地區別預測(2020年∼2027年)

Global Allergy Immunotherapy Market Size study, by Treatment (Subcutaneous Therapy, Sublingual Therapy ), Allergy, Distribution Channel and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球過敏免疫療法的市場規模在2019年估算為約29億美元,在2020年∼2027年的預測期間內,預計將以超越10.85%的成長率增長。過敏原免疫療法是一種避免因水果,花粉,灰塵,蜂毒等引起的過敏反應的治療方法。在其他常見的過敏症中,過敏性免疫療法有助於控制患有過敏症的人的症狀,如鼻炎,哮喘和結膜炎。市場成長的主要因素有過敏性疾病的流行,對過敏治療的認識提高以及政府和非營利組織的高昂臨床研究與開發成本。但是合格從業人員的短缺和高昂的成本將抑制市場的增長。

本報告提供過敏免疫療法市場調查,提供市場概要,市場成長要素及阻礙因素分析,不同治療·過敏·各銷售管道·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 摘要整理

第2章 全球過敏免疫療法市場定義和範圍

第3章 全球過敏免疫療法市場動態

  • 過敏免疫療法市場影響分析

第4章 全球過敏免疫療法市場:產業分析

  • 波特五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球過敏免疫療法市場:不同治療

  • 市場概述
  • 全球過敏免疫療法市場-潛在性分析
  • 全球過敏免疫療法市場:估計與不同治療預測
  • 過敏免疫療法市場:子區隔分析
    • 皮下療法(SCIT)
    • 舌下療法(SLIT)

第6章 全球過敏免疫療法市場:各過敏

  • 市場概述
  • 全球過敏免疫療法市場-潛在性分析
  • 全球過敏免疫療法市場:估計與預測
  • 過敏免疫療法市場:子區隔分析
    • 過敏性鼻炎
    • 過敏性結膜炎
    • 過敏性氣喘
    • 蜂毒
    • 其他

第7章 全球過敏免疫療法市場:各流通管道

  • 市場概述
  • 全球過敏免疫療法市場-潛在性分析
  • 全球過敏免疫療法市場:估計與預測
  • 過敏免疫療法市場:子區隔分析
    • 醫院
    • 電子商務
    • 藥局

第8章 全球過敏免疫療法市場:各地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第9章 競爭資訊

  • 首位市場策略
  • 企業簡介
    • ALK
    • Stallergenes Greer
    • Allergy Therapeutics
    • Merck KGaA
    • HAL Allergy B.V.
    • Biomay AG
    • Anergis
    • Aimmune Therapeutics
    • Circassia
    • DBV Technologies

第10章 調查流程

目錄

Title:
Global Allergy Immunotherapy Market Size study, by Treatment (Subcutaneous Therapy (SCIT), Sublingual Therapy (SLIT)), Allergy (Allergic rhinitis, Allergic conjunctivitis, Allergic asthma, Stinging insect venom, Others), Distribution Channel (Hospitals, E-commerce, Pharmacy) and Regional Forecasts 2020-2027.

Global Allergy Immunotherapy Market is valued approximately USD 2.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.85 % over the forecast period 2020-2027. Allergy immunotherapy is a treatment for the avoidance of allergic reactions caused, among other factors, by fruit, grass pollen, dust, and bee venom. Among other common allergies, allergy immunotherapy helps control symptoms among people suffering from allergies such as rhinitis, asthma, and conjunctivitis. Immunotherapy for allergies requires daily doses that usually raise the dose in order to develop resistance in the patient. Due to the improved development of blocking antibodies that battle the foreign compounds that induce allergies, the patient's immune mechanism becomes less vulnerable with a gradual rise in dose. The market is driven by the prevalence of allergic diseases, Growing awareness about allergy care, High clinical R&D expenditure by governments and non-profit organizations. The key players of global Allergy Immunotherapy market have adopted various strategies to gain competitive advantage including product launch, mergers and acquisition, partnerships and agreements, investment, funding and others. For instance, In October 2017, DBV Technologies entered into an agreement with Stallergenes S.A. regarding research and development. For the prevention of allergies to birch. Additionally, The European Academy of Allergy and Clinical Immunology (EAACI) estimates that over 150 million people are actually suffering from chronic food allergies in Europe, representing 20 percent of the population of the country. Allergic rhinitis and asthma are the most common allergies, affecting 100 million and 70 million people, respectively. However, Global immunotherapy for allergies, the dearth of qualified practitioners, high procedure costs would restrain the market growth.

The regional analysis of global Allergy Immunotherapy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of growing awareness about allergy care, High clinical R&D expenditure by governments and non-profit organizations. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as global allergy immunotherapy, the prevalence of allergic diseases would create lucrative growth prospects for the Allergy Immunotherapy Market across Asia-Pacific region.

Major market player included in this report are:

  • Stallergenes Greer
  • ALK
  • Allergy Therapeutics
  • Merck KGaA
  • HAL Allergy B.V.
  • Biomay AG
  • Anergis
  • Aimmune Therapeutics
  • Circassia
  • DBV Technologies

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

  • Subcutaneous Therapy (SCIT)
  • Sublingual Therapy (SLIT)

By Allergy:

  • Allergic rhinitis
  • Allergic conjunctivitis
  • Allergic asthma
  • Stinging insect venom
  • Others

By Distribution Channel:

  • Hospitals
  • E-commerce
  • Pharmacy

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2027

Target Audience of the Global Allergy Immunotherapy Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Allergy Immunotherapy Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Allergy Immunotherapy Market, by Treatment, 2018-2027 (USD Billion)
    • 1.2.3. Allergy Immunotherapy Market, by Allergy, 2018-2027 (USD Billion)
    • 1.2.4. Allergy Immunotherapy Market, by Distribution Channel, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Allergy Immunotherapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Allergy Immunotherapy Market Dynamics

  • 3.1. Allergy Immunotherapy Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Allergy Immunotherapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Allergy Immunotherapy Market, by Treatment

  • 5.1. Market Snapshot
  • 5.2. Global Allergy Immunotherapy Market by Treatment, Performance - Potential Analysis
  • 5.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
  • 5.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 5.4.1. Subcutaneous Therapy (SCIT)
    • 5.4.2. Sublingual Therapy (SLIT)

Chapter 6. Global Allergy Immunotherapy Market, by Allergy

  • 6.1. Market Snapshot
  • 6.2. Global Allergy Immunotherapy Market by Allergy, Performance - Potential Analysis
  • 6.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Allergy 2017-2027 (USD Billion)
  • 6.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 6.4.1. Allergic rhinitis
    • 6.4.2. Allergic conjunctivitis
    • 6.4.3. Allergic asthma
    • 6.4.4. Stinging insect venom
    • 6.4.5. Others

Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Allergy Immunotherapy Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
  • 7.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. E-commerce
    • 7.4.3. Pharmacy

Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis

  • 8.1. Allergy Immunotherapy Market, Regional Market Snapshot
  • 8.2. North America Allergy Immunotherapy Market
    • 8.2.1. U.S. Allergy Immunotherapy Market
      • 8.2.1.1. Treatment breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Allergy breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Allergy Immunotherapy Market
  • 8.3. Europe Allergy Immunotherapy Market Snapshot
    • 8.3.1. U.K. Allergy Immunotherapy Market
    • 8.3.2. Germany Allergy Immunotherapy Market
    • 8.3.3. France Allergy Immunotherapy Market
    • 8.3.4. Spain Allergy Immunotherapy Market
    • 8.3.5. Italy Allergy Immunotherapy Market
    • 8.3.6. Rest of Europe Allergy Immunotherapy Market
  • 8.4. Asia-Pacific Allergy Immunotherapy Market Snapshot
    • 8.4.1. China Allergy Immunotherapy Market
    • 8.4.2. India Allergy Immunotherapy Market
    • 8.4.3. Japan Allergy Immunotherapy Market
    • 8.4.4. Australia Allergy Immunotherapy Market
    • 8.4.5. South Korea Allergy Immunotherapy Market
    • 8.4.6. Rest of Asia Pacific Allergy Immunotherapy Market
  • 8.5. Latin America Allergy Immunotherapy Market Snapshot
    • 8.5.1. Brazil Allergy Immunotherapy Market
    • 8.5.2. Mexico Allergy Immunotherapy Market
  • 8.6. Rest of The World Allergy Immunotherapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. ALK
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Stallergenes Greer
    • 9.2.3. Allergy Therapeutics
    • 9.2.4. Merck KGaA
    • 9.2.5. HAL Allergy B.V.
    • 9.2.6. Biomay AG
    • 9.2.7. Anergis
    • 9.2.8. Aimmune Therapeutics
    • 9.2.9. Circassia
    • 9.2.10. DBV Technologies

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. GLOBAL Allergy Immunotherapy Market, REPORT SCOPE
  • TABLE 2. GLOBAL Allergy Immunotherapy Market ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL Allergy Immunotherapy Market ESTIMATES & FORECASTS BY TREATMENT 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL Allergy Immunotherapy Market ESTIMATES & FORECASTS BY ALLERGY 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL Allergy Immunotherapy Market BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL Allergy Immunotherapy Market BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL Allergy Immunotherapy Market BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL Allergy Immunotherapy Market BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL Allergy Immunotherapy Market BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL Allergy Immunotherapy Market BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL Allergy Immunotherapy Market BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL Allergy Immunotherapy Market BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL Allergy Immunotherapy Market BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL Allergy Immunotherapy Market BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. U.S. Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. U.S. Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 17. U.S. Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 18. CANADA Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 19. CANADA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 21. UK Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 22. UK Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 24. GERMANY Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 25. GERMANY Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 27. ROE Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 28. ROE Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 30. CHINA Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 31. CHINA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 33. INDIA Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 34. INDIA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 36. JAPAN Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 37. JAPAN Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 39. ROAPAC Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 40. ROAPAC Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 42. BRAZIL Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 43. BRAZIL Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 45. MEXICO Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 46. MEXICO Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 48. ROLA Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 49. ROLA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 51. ROW Allergy Immunotherapy Market ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 52. ROW Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW Allergy Immunotherapy Market ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL Allergy Immunotherapy Market
  • TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL Allergy Immunotherapy Market
  • TABLE 56. YEARS CONSIDERED FOR THE STUDY
  • TABLE 57. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL Allergy Immunotherapy Market, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL Allergy Immunotherapy Market, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL Allergy Immunotherapy Market, KEY TRENDS 2019
  • FIG 5. GLOBAL Allergy Immunotherapy Market, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL Allergy Immunotherapy Market, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL Allergy Immunotherapy Market, PEST ANALYSIS
  • FIG 8. GLOBAL Allergy Immunotherapy Market, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL Allergy Immunotherapy Market BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL Allergy Immunotherapy Market BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL Allergy Immunotherapy Market BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL Allergy Immunotherapy Market BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL Allergy Immunotherapy Market BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL Allergy Immunotherapy Market, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA Allergy Immunotherapy Market 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE Allergy Immunotherapy Market 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC Allergy Immunotherapy Market 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA Allergy Immunotherapy Market 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL Allergy Immunotherapy Market, COMPANY MARKET SHARE ANALYSIS (2019)